Wells Fargo’s Trillium Therapeutics Inc. TRIL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
Sell
-4,620
Closed -$81K 7681
2021
Q3
$81K Sell
4,620
-13,028
-74% -$228K ﹤0.01% 5167
2021
Q2
$172K Sell
17,648
-1,625
-8% -$15.8K ﹤0.01% 4791
2021
Q1
$206K Buy
19,273
+4,580
+31% +$49K ﹤0.01% 4818
2020
Q4
$216K Buy
14,693
+725
+5% +$10.7K ﹤0.01% 4914
2020
Q3
$198K Buy
13,968
+8,968
+179% +$127K ﹤0.01% 4803
2020
Q2
$40K Buy
5,000
+1,700
+52% +$13.6K ﹤0.01% 5273
2020
Q1
$13K Sell
3,300
-7,300
-69% -$28.8K ﹤0.01% 5425
2019
Q4
$11K Buy
10,600
+4,250
+67% +$4.41K ﹤0.01% 5560
2019
Q3
$2K Sell
6,350
-1,500
-19% -$472 ﹤0.01% 5767
2019
Q2
$3K Sell
7,850
-2,750
-26% -$1.05K ﹤0.01% 5697
2019
Q1
$7K Sell
10,600
-600
-5% -$396 ﹤0.01% 5574
2018
Q4
$19K Sell
11,200
-21,289
-66% -$36.1K ﹤0.01% 5446
2018
Q3
$189K Sell
32,489
-3,150
-9% -$18.3K ﹤0.01% 4855
2018
Q2
$214K Buy
35,639
+9,379
+36% +$56.3K ﹤0.01% 4824
2018
Q1
$189K Buy
26,260
+160
+0.6% +$1.15K ﹤0.01% 4820
2017
Q4
$189K Buy
26,100
+9,550
+58% +$69.2K ﹤0.01% 4802
2017
Q3
$85K Buy
16,550
+1,000
+6% +$5.14K ﹤0.01% 5058
2017
Q2
$69K Sell
15,550
-2,150
-12% -$9.54K ﹤0.01% 5058
2017
Q1
$109K Buy
17,700
+4,500
+34% +$27.7K ﹤0.01% 4925
2016
Q4
$75K Buy
13,200
+1,400
+12% +$7.96K ﹤0.01% 5024
2016
Q3
$175K Buy
11,800
+10,800
+1,080% +$160K ﹤0.01% 4384
2016
Q2
$9K Hold
1,000
﹤0.01% 5414
2016
Q1
$9K Hold
1,000
﹤0.01% 5491
2015
Q4
$13K Hold
1,000
﹤0.01% 5415
2015
Q3
$13K Buy
+1,000
New +$13K ﹤0.01% 5399